Total Payments
$53,539
2024 Payments
$2,478
Companies
41
Transactions
929
Medicare Patients
724
Medicare Billing
$110,241
Payment Breakdown by Category
Other$31,890 (59.6%)
Food & Beverage$18,963 (35.4%)
Travel$2,213 (4.1%)
Education$323.49 (0.6%)
Consulting$150.00 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $31,890 | 15 | 59.6% |
| Food and Beverage | $18,963 | 883 | 35.4% |
| Travel and Lodging | $2,213 | 20 | 4.1% |
| Education | $323.49 | 10 | 0.6% |
| Consulting Fee | $150.00 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $35,436 | 102 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $2,051 | 87 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $1,706 | 70 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $1,526 | 44 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $1,414 | 54 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $1,280 | 48 | $0 (2024) |
| ITI, Inc. | $1,257 | 63 | $0 (2023) |
| Supernus Pharmaceuticals, Inc. | $1,208 | 43 | $0 (2024) |
| Allergan, Inc. | $1,026 | 51 | $0 (2020) |
| Neos Therapeutics, LP | $809.57 | 38 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,478 | 113 | Teva Pharmaceuticals USA, Inc. ($593.81) |
| 2023 | $2,274 | 115 | ITI, Inc. ($564.54) |
| 2022 | $2,221 | 107 | ITI, Inc. ($469.75) |
| 2021 | $1,860 | 120 | Otsuka America Pharmaceutical, Inc. ($294.32) |
| 2020 | $1,569 | 88 | Allergan, Inc. ($220.98) |
| 2019 | $10,967 | 116 | Alkermes, Inc. ($8,257) |
| 2018 | $15,155 | 128 | Alkermes, Inc. ($12,342) |
| 2017 | $17,016 | 142 | Alkermes, Inc. ($14,216) |
All Payment Transactions
929 individual payment records from CMS Open Payments — Page 1 of 38
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Bausch Health US, LLC | APLENZIN (Drug), WELLBUTRIN | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Neurology | ||||||
| 12/18/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/10/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Central Nervous System | ||||||
| 12/01/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: PSYCHIATRY | ||||||
| 11/28/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: PSYCHIATRY | ||||||
| 11/19/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $24.07 | General |
| Category: Neuropsychiatry | ||||||
| 11/18/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $23.76 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/14/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $27.64 | General |
| Category: PSYCHIATRY | ||||||
| 11/12/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: Central Nervous System | ||||||
| 11/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug) | Food and Beverage | Cash or cash equivalent | $15.94 | General |
| Category: ADHD | ||||||
| 11/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.24 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: Neuropsychiatry | ||||||
| 10/29/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $8.82 | General |
| Category: PSYCHIATRY | ||||||
| 10/24/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: PSYCHIATRY | ||||||
| 10/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Central Nervous System | ||||||
| 10/07/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: PSYCHIATRY | ||||||
| 09/30/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $9.70 | General |
| Category: Neuropsychiatry | ||||||
| 09/25/2024 | Noven Therapeutics, LLC | Xelstrym (Drug), Secuado | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: ADHD | ||||||
| 09/24/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: Neurology | ||||||
| 09/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: NEUROSCIENCE | ||||||
| 09/16/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $11.05 | General |
| Category: PSYCHIATRY | ||||||
| 09/11/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.53 | General |
| Category: PSYCHIATRY | ||||||
| 09/09/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 153 | 400 | $65,460 | $22,847 |
| 2022 | 2 | 140 | 416 | $62,455 | $25,715 |
| 2021 | 2 | 172 | 491 | $75,405 | $30,600 |
| 2020 | 5 | 259 | 590 | $90,880 | $31,079 |
Total Patients
724
Total Services
1,897
Medicare Billing
$110,241
Procedure Codes
12
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 100 | 322 | $48,280 | $16,292 | 33.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 29 | 54 | $14,210 | $4,789 | 33.7% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 24 | 24 | $2,970 | $1,766 | 59.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 111 | 381 | $54,195 | $22,515 | 41.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 29 | 35 | $8,260 | $3,201 | 38.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 128 | 433 | $61,775 | $26,087 | 42.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 44 | 58 | $13,630 | $4,513 | 33.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 149 | 445 | $61,720 | $22,501 | 36.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 54 | 68 | $15,340 | $4,354 | 28.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 19 | 19 | $8,440 | $2,129 | 25.2% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 26 | 28 | $2,790 | $1,807 | 64.8% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 11 | 30 | $2,590 | $288.15 | 11.1% |
About Dr. Devendra Shah, M.D
Dr. Devendra Shah, M.D is a Psychiatry healthcare provider based in Monroe, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/26/2005. The National Provider Identifier (NPI) number assigned to this provider is 1164418125.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Devendra Shah, M.D has received a total of $53,539 in payments from pharmaceutical and medical device companies, with $2,478 received in 2024. These payments were reported across 929 transactions from 41 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($31,890).
As a Medicare-enrolled provider, Shah has provided services to 724 Medicare beneficiaries, totaling 1,897 services with total Medicare billing of $110,241. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Monroe, NC
- Active Since 09/26/2005
- Last Updated 12/20/2024
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1164418125
Products in Payments
- Aristada 441 mg (Drug) $26,408
- ARISTADA (Drug) $8,800
- INGREZZA (Drug) $1,706
- CAPLYTA (Drug) $1,551
- LATUDA (Drug) $1,526
- VRAYLAR (Drug) $1,405
- REXULTI (Drug) $1,305
- INVEGA SUSTENNA (Drug) $821.14
- Adzenys XR-ODT (Drug) $794.66
- ABILIFY MAINTENA (Drug) $738.63
- TRINTELLIX (Drug) $511.89
- SPRAVATO (Drug) $501.44
- AUSTEDO (Drug) $439.29
- APLENZIN (Drug) $414.60
- QELBREE (Drug) $402.18
- Austedo XR (Drug) $391.30
- Dyanavel XR (Drug) $350.81
- MYDAYIS (Drug) $276.51
- SUBOXONE SUBLINGUAL FILM (Drug) $250.00
- Trintellix (Drug) $242.58
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Monroe
Dr. Manzar Rajput, Md, MD
Psychiatry — Payments: $431,101
Psychiatry $431,101
Dr. Aruna Gullapalli, Md, MD
Psychiatry — Payments: $31,128
Psychiatry $31,128
Dr. Alfredo Torres, Md, MD
Psychiatry — Payments: $13,665
Psychiatry $13,665
Dr. Paul Gutterman, Md, MD
Psychiatry — Payments: $10,115
Psychiatry $10,115
Dr. Chin Ho Pak, M.d, M.D
Psychiatry — Payments: $7,914
Psychiatry $7,914
Dr. Mubeen Memon, M.d, M.D
Psychiatry — Payments: $4,421
Psychiatry $4,421